These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 33708391)
61. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects. Cui W; He Z; Zhang Y; Fan Q; Feng N AAPS PharmSciTech; 2019 Feb; 20(3):115. PubMed ID: 30771018 [TBL] [Abstract][Full Text] [Related]
62. Mechanochemistry: A Green Approach in the Preparation of Pharmaceutical Cocrystals. Solares-Briones M; Coyote-Dotor G; Páez-Franco JC; Zermeño-Ortega MR; de la O Contreras CM; Canseco-González D; Avila-Sorrosa A; Morales-Morales D; Germán-Acacio JM Pharmaceutics; 2021 May; 13(6):. PubMed ID: 34070646 [TBL] [Abstract][Full Text] [Related]
63. From Molecules to Interactions to Crystal Engineering: Mechanical Properties of Organic Solids. Saha S; Mishra MK; Reddy CM; Desiraju GR Acc Chem Res; 2018 Nov; 51(11):2957-2967. PubMed ID: 30351918 [TBL] [Abstract][Full Text] [Related]
64. Patterns in the quinary structures of proteins. Plasticity and inequivalence of individual molecules in helical arrays of sickle cell hemoglobin and tubulin. Edelstein SJ Biophys J; 1980 Oct; 32(1):347-60. PubMed ID: 7248453 [TBL] [Abstract][Full Text] [Related]
65. Praziquantel Fifty Years on: A Comprehensive Overview of Its Solid State. D'Abbrunzo I; Procida G; Perissutti B Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258039 [TBL] [Abstract][Full Text] [Related]
66. Development of a pharmaceutical cocrystal with solution crystallization technology: Preparation, characterization, and evaluation of myricetin-proline cocrystals. Liu M; Hong C; Yao Y; Shen H; Ji G; Li G; Xie Y Eur J Pharm Biopharm; 2016 Oct; 107():151-9. PubMed ID: 27395394 [TBL] [Abstract][Full Text] [Related]
67. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics. Shan N; Perry ML; Weyna DR; Zaworotko MJ Expert Opin Drug Metab Toxicol; 2014 Sep; 10(9):1255-71. PubMed ID: 25089559 [TBL] [Abstract][Full Text] [Related]
68. Mechanochemical Approaches to Pharmaceutical Cocrystal Formation and Stability Analysis. Lin SY Curr Pharm Des; 2016; 22(32):5001-5018. PubMed ID: 27464722 [TBL] [Abstract][Full Text] [Related]
69. Cocrystals of a coumarin derivative: an efficient approach towards anti-leishmanial cocrystals against MIL-resistant Leishmania tropica. Shahbaz M; Farooq S; Choudhary MI; Yousuf S IUCrJ; 2024 Mar; 11(Pt 2):224-236. PubMed ID: 38427455 [TBL] [Abstract][Full Text] [Related]
70. Synthetic Approaches to Halogen Bonded Ternary Cocrystals. Jain H; Sutradhar D; Roy S; Desiraju GR Angew Chem Int Ed Engl; 2021 Jun; 60(23):12841-12846. PubMed ID: 33779114 [TBL] [Abstract][Full Text] [Related]
71. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions. Sanphui P; Devi VK; Clara D; Malviya N; Ganguly S; Desiraju GR Mol Pharm; 2015 May; 12(5):1615-22. PubMed ID: 25800383 [TBL] [Abstract][Full Text] [Related]
72. Uracil Derivatives for Halogen-Bonded Cocrystals. Benito M; Roselló Y; Barceló-Oliver M; Frontera A; Molins E Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639004 [TBL] [Abstract][Full Text] [Related]
73. Structural Landscape of α-Acetamidocinnamic Acid Cocrystals with Bipyridine-Based Coformers: Influence of Crystal Packing on Their Thermal and Photophysical Properties. Ejarque D; Calvet T; Font-Bardia M; Pons J Cryst Growth Des; 2024 Feb; 24(4):1746-1765. PubMed ID: 38405168 [TBL] [Abstract][Full Text] [Related]
74. Green Grinding-Coassembly Engineering toward Intrinsically Luminescent Tetracene in Cocrystals. Huang Y; Gong Q; Ge J; Tang P; Yu F; Xiao L; Wang Z; Sun H; Yu J; Li DS; Xiong Q; Zhang Q ACS Nano; 2020 Nov; 14(11):15962-15972. PubMed ID: 33112602 [TBL] [Abstract][Full Text] [Related]
75. Critical Analysis and Optimization of Stoichiometric Ratio of Drug-Coformer on Cocrystal Design: Molecular Docking, In Vitro and In Vivo Assessment. Dhibar M; Chakraborty S; Basak S; Pattanayak P; Chatterjee T; Ghosh B; Raafat M; Abourehab MAS Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259428 [TBL] [Abstract][Full Text] [Related]
76. Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development. Gadade DD; Pekamwar SS Adv Pharm Bull; 2016 Dec; 6(4):479-494. PubMed ID: 28101455 [TBL] [Abstract][Full Text] [Related]
77. Challenges and opportunities of pharmaceutical cocrystals: a focused review on non-steroidal anti-inflammatory drugs. Garg U; Azim Y RSC Med Chem; 2021 May; 12(5):705-721. PubMed ID: 34124670 [TBL] [Abstract][Full Text] [Related]
78. Recent Patents of Pharmaceutical Co-Crystals: Product Development on Anti-Cancer Drugs and Beyond. Tharik AAMS; Meyyanathan SN Recent Pat Anticancer Drug Discov; 2023; 18(3):246-267. PubMed ID: 36100994 [TBL] [Abstract][Full Text] [Related]
79. Understanding solid-state processing of pharmaceutical cocrystals via milling: Role of tablet excipients. Shaikh R; Shirazian S; Guerin S; Sheehan E; Thompson D; Walker GM; Croker DM Int J Pharm; 2021 May; 601():120514. PubMed ID: 33766638 [TBL] [Abstract][Full Text] [Related]